# Safety and Efficacy of Low-dose Ticagrelor in Chinese Patients With Stable Coronary Artery Disease

> **NCT02514642** · PHASE4 · UNKNOWN · sponsor: **First Affiliated Hospital of Harbin Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** low-dose ticagrelor
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT02514642
- **Lead sponsor:** First Affiliated Hospital of Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2015-10
- **Final completion:** 2015-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2015-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02514642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02514642, "Safety and Efficacy of Low-dose Ticagrelor in Chinese Patients With Stable Coronary Artery Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02514642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*